Skip to content
Review Open access

Current state of blood pressure measurement in pregnant people in Canada: A national, inter-disciplinary survey.

Jul 2026 · Journal of Obstetrics and Gynaecology Canada · Vol 48, pp. 103469 · 0 citations · 20 references
Medicine

TL;DR

The most concerning finding is failure to use and recommend devices validated in pregnancy for pregnant people, due at least in part, to the limited number of devices validated for this population.

Abstract

Objective

Hypertension impacts 26 900 pregnancies in Canada per year. Accurate blood pressure (BP) measurement is recognized as crucial to hypertension care outside pregnancy but has gained less attention in pregnancy. Canadian guidelines recommend measuring maternal BP with a manual auscultatory device, or an automated device validated in pregnancy. National adherence to this recommendation is unknown.

Methods

We developed a 15-question survey to understand how health care professionals (HCPs) measure BP in pregnancy. We distributed it through Hypertension Canada's mailing list and the Snowball method.

Results

86 HCPs from 7 provinces and various specialties (including 63% from internal medicine and 21% from obstetrics) responded. For clinic BP in pregnant people, respondents frequently use an appropriate cuff size (n = 82, 95%), take multiple readings (n = 77, 90%), and have patients sit with arm/back support (n = 72, 84%). HCPs often use automated clinic devices for pregnant people but are uncertain of their validation in pregnancy (n = 53, 62%). Respondents frequently recommended home BP measurement (n = 81, 94%) and asked patients to bring home devices in to compare against clinic devices (n = 61, 71%) but most did not recommend a specific home device nor specify one that is validated in pregnancy.

Conclusions

We identified four strengths of BP measurement in pregnancy: appropriate cuff size, taking multiple readings, recommending home measurement, and attempting calibration of home devices. The most concerning finding is failure to use (in clinic) and recommend (at home) devices validated for pregnant people, due at least in part, to the limited number of devices validated for this population.

Read PDF

Similar papers

Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in the Republic of Ireland and the United Kingdom

The MMM campaign identified substantial numbers of participants with untreated or inadequately treated hypertension, which reinforces the urgent need for more effective hypertension detection and control strategies to abate the rising hypertension burden.

K. Stone, Abbie R Williams, Christopher J A Pugh et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Egypt

The MMM campaign in Egypt identified a substantial number of participants with untreated or inadequately treated hypertension, underscoring a high burden and persistent gaps in detection and management and highlighting the need for public education, clinical management, and community-centric screening and interventions...

Marina Sous, Farah Bishay, Esraa Magdy et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Nepal

The MMM campaign in Nepal identified a substantial number of participants with untreated or inadequately treated hypertension, and the need to strengthen community-based programs to enhance the continuum of hypertension detection and management is highlighted.

Zheng-Bang Yao, Y. Inagaki, S. Koirala et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Vietnam

The MMM campaign in Vietnam identified a substantial number of participants with untreated or inadequately treated hypertension, which underscores the urgent need for strengthened national strategies to improve hypertension screening, treatment accessibility, and long-term blood pressure control.

M. Van, Viet Nguyen Lan, Son Tran Kim et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Ghana

The MMM campaign in Ghana identified a substantial number of participants with untreated or inadequately treated hypertension, which is significant to note that the annual BP screening campaign is a means to create awareness of the need to get screened and also identify individuals with high BP.

Betty Owusu-Ansah, Joseph O Kiddy-Kodua, Martin Adu-Adadey et al. · 0 citations
Open access Jul 2026

Mind the evidence gap: lack of validated blood pressure devices for pregnant patients.

Evidence shows automated devices can produce clinically meaningful inaccuracies, leading to under- or overdiagnosis of hypertensive disorders of pregnancy, and addressing this issue requires pregnancy-specific validation studies, regulatory attention, and increased clinical awareness to ensure accurate and equitable ma...

Aleena Sajid, L. Dubrofsky, Shital Gandhi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.